Home / Diseases / Telemedicine visits comparable for glycemic control in T1DM
продажа авиабилетов

Telemedicine visits comparable for glycemic control in T1DM

Telemedicine visits comparable for glycemic control in T1DM

(HealthDay)—Among patients with type 1 diabetes and suboptimal glycemic control, replacement of an intermediate face-to-face visit with a telemedicine session did not affect outcomes, according to a study published online Jan. 6 in Diabetes Care.

Maria S. Ruiz de Adana, M.D., Ph.D., from the Hospital Regional Universitario de Málaga in Spain, and colleagues randomly assigned 379 with type 1 and suboptimal metabolic control (glycated hemoglobin [HbA1c]

The researchers found that at month 6, the mean change in HbA1c levels was −0.04 in the control group and 0.01 in the intervention group. In the two groups, the number of patients who achieved HbA1c

“The study allows us to prove the advantages of this innovative care option in the usual follow-up of this specific profile of people with type 1 diabetes and shows that telemedicine may improve patient access to health care and diabetes management in some geographic areas,” the authors write.

The study was funded by Sanofi.


Study explores factors affecting glycemic control in T1DM


More information:
Abstract/Full Text (subscription or payment may be required)

Copyright © 2020 HealthDay. All rights reserved.

Citation:
Telemedicine visits comparable for glycemic control in T1DM (2020, January 13)
retrieved 13 January 2020
from https://medicalxpress.com/news/2020-01-telemedicine-glycemic-t1dm.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.


Source link

Check Also

Experts warn over scale of China virus as US airports start screening

The outbreak centred around a seafood market in the central city of Wuhan The true …

120*600 120*600